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Precis: Systematic collection of high-quality data on sexual and gender minority status is 
fundamental to assessing and monitoring the burden of cancer in this understudied and 
underserved population. The majority of hospitals do not collect these data and physicians 
offices do not perceive the data to be medically relevant.
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Based on latest estimates, in the United States (U.S.), there are currently approximately 9 
million lesbian, gay, bisexual, transgender and queer (LGBTQ), also known as sexual and 
gender minority (SGM), individuals (1). The unique health needs and burden of disease, 
including cancer, in this population is increasingly recognized as evidenced by designation by 
the National Institute of Minority Health and Health Disparities (Director’s message: 
https://www.nimhd.nih.gov/about/directors-corner/message.html) of SGMs as a health disparity 
population. There are limited data available on the burden of cancer among SGM men and 
women. In this issue of Cancer, Kent et al. reviewed the literature on cancer care for SGM 
populations. This review illustrates the severe lack of population-based studies on SGM 
patients, which limits the recognition of cancer and other health disparities in this underserved 
and understudied population (2). Using an ecological approach, a study across all registries of 
the Surveillance, Epidemiology, and End Results (SEER) Program showed that lung cancer 
incidence and mortality rates are higher in counties with a higher density of sexual minority men, 
whereas the reverse was found in counties with a higher density of sexual minority women (3). 
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transmitted infections-related cancers (4), with the most frequent cancers being anal and liver 
cancer, and Kaposi sarcoma, related to human papillomavirus (HPV), Epstein-Barr virus, and 
herpes virus 8, respectively. Among women who have sex with women (WSW), Meads and 
Moore (5) evaluated the literature on breast cancer and found that results from five studies were 
inconsistent regarding whether lesbian and bisexual women had higher risks than heterosexual 
women, primarily due to the studies having small number of patients and being of generally 
limited quality. The authors emphasized the need for more research to fill the knowledge gap of 
the burden of cancer (and other diseases) among SGM populations (4). Systematic collection of 
high-quality data on SGM status is fundamental to assessing and monitoring the burden of 
cancer, including incidence, survival, and mortality rates, as well as contributing factors, in this 
vulnerable population. A position statement from the American Society of Clinical Oncology 
(ASCO) in 2017 recommended increased data collection on SGMs to inform future work 
addressing their health needs, including SGM data collection by cancer registries (6).
Data collected by diagnosing and treating hospitals and doctors’ offices are the predominant 
source of information on new cancers for population-based cancer registries. In the North 
American Association for Central Cancer Registries (NAACCR) data dictionary, the variable 
“sex” has several options beyond male and female, including Other (intersex, disorders of 
sexual development); transsexual or transgender, not otherwise specified; transsexual or 
transgender, natal male; and transsexual or transgender, natal female. However, despite these 
categories, it is unknown the extent to which sexual orientation and gender identity information 
is systematically collected by hospitals and doctors’ offices. In the San Francisco Bay Area, a 
feasibility assessment conducted by the Greater Bay Area Cancer Registry showed that gender 
identity and sexual orientation information are not systematically captured within most hospitals 
and doctors’ practices in the region, an area with the highest proportion of SGM in the U.S. (7) 
Some facilities and practices did capture ‘other’ gender and sexual orientation categories (either 
as an open-ended field, or by clinician observation, or if a patient provided this information), but 
this information was, for the most part, not collected in a systematic way. In the feasibility 
assessment, based on some surveys returned by physician offices and/or verbal interactions 
with office staff, the level of detail regarding data collection on sexual orientation and gender 
identity was limited and several comments were made that this information was “irrelevant,” “not 
necessary for their patient’s care,” “was too intrusive,” or “only recorded IF it was related to the 
patient’s medical condition.” Contrary to these sentiments, several comments were made by 
cancer registrars who abstract data from hospitals that sexual orientation and gender identity 















This article is protected by copyright. All rights reserved
systematically”, “our facility just recently began…” or “will soon begin collecting these data”, or 
“we need questions like this added to our [patient intake/registration] form”. It was heartening to 
learn that several hospitals and integrated healthcare systems in the region already do or are 
actively working on incorporating these SGM-related items into intake forms, and asking 
patients about sexual orientation and gender identity status in a more consistent and 
standardized way. This feasibility survey for hospital administrators, physician offices, and 
certified tumor registrars are available from the first author upon request.
Cancer registries collect data according to rules and guidelines from the standard setters, such 
as NAACCR and SEER. Although the NAACCR sex variable already accommodates several 
categories of gender identity, they are likely under-utilized; in the Greater Bay Area Cancer 
Registry, from the period 1988-2014, only 115 cases (0.015%), were coded as transsexual. As 
with any new data item, the standard setters should expand the requirements to collect gender 
identity and sexual orientation data from all cancer registries. However, they should first work 
with national accreditation organizations such as ASCO, National Cancer Institute (NCI), 
American College of Surgeons, etc., to develop guidelines and requirements for collection of 
additional key patient sociodemographic data including SGM status. 
A national study showed that 78% of clinicians felt that their patients would refuse to disclose 
their SGM status, in stark contrast to only 10% of patients reporting that they would refuse to 
disclose their status, citing improved individualized care as a benefit to disclosure (8-10). In a 
recent national survey of nearly 150 oncologists from NCI-designated cancer centers across the 
U.S., Schabath and colleagues measured the attitudes, knowledge, institutional practice 
behaviors, and interest in education on the care of LGBTQ patients with cancer (11). They 
found that while the majority, about two-thirds, of oncologists felt that it was important to know a 
patient’s gender identity, only about one-third felt that it was relevant to them to know of the 
patient’s sexual orientation. Although there was generally limited knowledge regarding LGBTQ 
cancer needs, more than 70% indicated interest in receiving education regarding the unique 
oncology needs for this population. Our cancer registry feasibility assessment showed that, in 
the San Francisco Bay Area, the leaders of large healthcare systems and hospitals are willing to 
collect SGM data and likely would do so if mandated for cancer registry reporting or for 
accreditation. However, independent community physician practices, which are reporting an 
increasing proportion of new cancer diagnoses, will need additional motivations to collect SGM 
data, in addition to basic social determinants data such as self-reported race and ethnicity. This 
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and treated only in doctors’ offices. Training as well as data collection tools are needed to 
encourage doctors’ offices to appreciate the importance of social determinants in the context of 
the medical care they are providing, and to facilitate data collection on social determinants of 
health, including SGM status. The development and implementation of tools for data collection 
is a process that should involve engagement of clinicians and patients. Clinicians should be 
reassured that the vast majority of patients nationwide welcome being asked about SGM status 
and related information, and the patient voice can be powerful in this regard. 
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